Predictors of Anticoagulant Treatment in Patients With Nonvalvular Atrial Fibrillation: Results From Atrial Fibrillation in Turkey: Epidemiologic Registry

Basit Öğe Kaydı
dc.contributor.authorKaya, Hasan
dc.contributor.authorErtas, Faruk
dc.contributor.authorKoroglu, Bayram
dc.contributor.authorVatan, Bulent
dc.contributor.authorCagliyan, Caglar Emre
dc.contributor.authorGedik, Selcuk
dc.contributor.authorYeter, Ekrem
dc.date.accessioned2024-04-24T17:14:39Z
dc.date.available2024-04-24T17:14:39Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe aim of the study was to assess the factors associated with the anticoagulation treatment in patients with atrial fibrillation (AF). A total of 2242 consecutive patients who had been admitted with AF on their electrocardiogram were included in the study. After excluding valvular AF, 1745 patients with nonvalvular AF were analyzed. Mean CHA2DS2-VASc score [cardiac failure, hypertension, age >= 75 (doubled), diabetes, stroke (doubled), vascular disease, age 65 -74 and sex category (female)], frequency of persistent/permanent AF, hypertension, diabetes mellitus (DM), stroke history, body mass index, and left atrial diameter were significantly higher in patients receiving anticoagulant therapy. Stroke history, persistent/permanent AF, hypertension, DM, age, heart failure, and left atrial diameter were independent predictors of warfarin prescription. Labile international normalized ratio was the only independent negative predictor of effective treatment with warfarin. In this study, we demonstrated that stroke history, persistent/permanent AF, hypertension, DM, and left atrial diameter were positive predictors, whereas advanced age and heart failure were negative predictors of oral anticoagulant use in patients with nonvalvular AF.en_US
dc.identifier.doi10.1177/1076029613491459
dc.identifier.endpage148en_US
dc.identifier.issn1076-0296
dc.identifier.issn1938-2723
dc.identifier.issue2en_US
dc.identifier.pmid23742948
dc.identifier.scopus2-s2.0-84923002524
dc.identifier.scopusqualityQ2
dc.identifier.startpage144en_US
dc.identifier.urihttps://doi.org/10.1177/1076029613491459
dc.identifier.urihttps://hdl.handle.net/11468/18115
dc.identifier.volume21en_US
dc.identifier.wosWOS:000350492000007
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofClinical and Applied Thrombosis-Hemostasis
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAtrial Fibrillationen_US
dc.subjectNonvalvularen_US
dc.subjectPredictoren_US
dc.subjectAnticoagulant Treatmenten_US
dc.titlePredictors of Anticoagulant Treatment in Patients With Nonvalvular Atrial Fibrillation: Results From Atrial Fibrillation in Turkey: Epidemiologic Registryen_US
dc.titlePredictors of Anticoagulant Treatment in Patients With Nonvalvular Atrial Fibrillation: Results From Atrial Fibrillation in Turkey: Epidemiologic Registry
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu